Adeona Pharmaceuticals, Inc. (AEN) Reports Q3 Loss of $0.04

Adeona Pharmaceuticals, Inc. (NYSE: AEN) reported Q3 EPS of ($0.04), versus ($0.03) reported last year. Revenue for the quarter came in at $293.42 thousand, versus $289.9 thousand reported last year.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• The Gap, Inc. (GAP) Tops Q2 EPS by 3c
• Hormel Foods (HRL) Tops Q3 EPS by 2c, Misses on Revenue; Offers FY26 Guidance
• Dollar General (DG) Tops Q2 EPS by 48c, Beats on Revenue; Offers FY27 EPS Guidance